[1]Machicado J.D., Yadav D. Epidemiology of recurrent acute and chronic pancreatitis: Similarities and Differences. Dig Dis Sci. 2017;62:1683-1691.
[2]Omdal T., Dale J., Lie S.A. Time trends in incidence, etiology, and case fatality rate of the first attack of acute pancreatitis. Scand J Gastroenterol. 2011;46:1389-1398.
[3]Roberts SE, Morrison-Rees S, John A, et al. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology 2017 ; 17 : 155-65.
[4]Krishna S.G., Kamboj A.K., Hart P.A. The changing epidemiology of acute pancreatitis hospitalizations: A decade of trends and the impact of chronic pancreatitis. Pancreas. 2017;46:482-488.
[5]Vedie AL, Perozzielo A, Belaid J, et al. Etude de la mortalité de la pancréatite aiguë à partir des données nationales PMSI en France en 2013-2014. JFHOD 2017 (abst.).
[6]Karjula H, Saarela A, Ohtonen P, et al. Long-term outcome and causes of death for working-age patients hospitalized due to acute pancreatitis with a median follow-up of 10 years. Ann Surg 2017 Dec 4. doi : 10.1097/SLA.0000000000002612.
[7]van Dijk SM, Hallensleben NDL, van Santvoort HC, et al. Acute pancreatitis : recent advances through randomised trials. Gut 2017 ; 66 : 2024-32.
[8]Working Group, IAP/APA, Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013 ; 13 : 1-15.
[9]Chang K., Lu W., Zhang K. Rapid urinary tryspinogen-2 test in the early diagnosis of acute pancreatitis : a meta-analysis. Clin Biochem. 2012;45:1051-1056.
[10]Lankisch P.G., Apte M., Banks P.A. Acute pancreatitis. Lancet. 2015;386:85-96.
[11]Pelletier A.L., Hammel P., Rebours V. Acute pancreatitis in patients operated on for intraductal papillary mucinous neoplasms of the pancreas: Frequency, severity, and clinicopathologic correlations. Pancreas. 2010;39:658-661.
[12]Morales-Oyarvide V., Mino-Kenudson M., Ferrone C.R. Acute pancreatitis in intraductal papillary mucinous neoplasms: A common predictor of malignant intestinal subtype. Surgery. 2015;158:1219-1225.
[13]Adiamah A, Psaltis E, Crook M, Lobo DN. A systematic review of the epidemiology, pathophysiology and current management of hyperlipidaemic pancreatitis. Clin Nutr 2017 : S0261-5614(17)31360-2.
[14]Jalaly N.Y., Moran R.A., Fargahi F. An evaluation of factors associated with pathogenic PRSS1, SPINK1, CTFR, and/or CTRC genetic variants in patients with idiopathic pancreatitis. Am J Gastroenterol. 2017;112:1320-1329.
[15]Kanth R., Samji N.S., Inaganti A. Endotherapy in symptomatic pancreas divisum: A systematic review. Pancreatology. 2014;14:244-250.
[16]Liao Z1, Gao R., Wang W. A systematic review on endoscopic detection rate, endotherapy, and surgery for pancreas divisum. Endoscopy. 2009;41:439-444.
[17]Bertin C., Pelletier A.L., Vullierme M.P. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am J Gastroenterol. 2012;107:311-317.
[18]Coté G.A., Imperiale T.F., Schmidt S.E. Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis. Gastroenterology. 2012;143:1502-1509.
[19]van Geenen E.J., Smits M.M., Schreuder T.C. Smoking is related to pancreatic fibrosis in humans. Am J Gastroenterol. 2011;106:1161-1166.
[20]Sun X., Huang X., Zhao R. Meta-analysis: Tobacco smoking may enhance the risk of acute pancreatitis. Pancreatology. 2015;15:286-294.
[21]Culetto A., Bournet B., Haennig A. Prospective evaluation of the aetiological profile of acute pancreatitis in young adult patients. Dig Liver Dis. 2015;47:584-589.
[22]Levy P., Boruchowicz A., Hastier P. Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: Multicentre prospective evaluation of 213 patients. Pancreatology. 2005;5:450-456.
[23]van Geenen E.J., van der Peet D.L., Bhagirath P. Etiology and diagnosis of acute biliary pancreatitis. Nat Rev Gastroenterol Hepatol. 2010;7:495-502.
[24]Giljaca V., Gurusamy K.S., Takwoingi Y. Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones. Cochrane Database Syst Rev. 2015;2:CD011549.
[25]Wan J, Ouyang Y, Yu C, et al. Comparison of EUS with magnetic resonance cholangiopancreatography in idiopathic acute pancreatitis : a systematic review and meta-analysis. Gastrointest Endosc 2017 dec 7. pii : S0016-5107(17)32534-8.
[26]Catalano MF, Sahai A, Levy M, et al. EUS-based criteria for the diagnosis of chronic pancreatitis: The Rosemont classification. Gastrointest Endosc 2009 ; 69 : 1251-61.
[27]Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: Revision of the Atlanta classification and definitions by international consensus. Gut 2013 ; 62 : 102-11.
[28]Kadiyala V., Suleiman S.L., McNabb-Baltar J. The Atlanta Classification, Revised Atlanta Classification, and Determinant-Based Classification of Acute Pancreatitis: Which Is Best at Stratifying Outcomes ? Pancreas. 2016;45:510-515.
[29]Papachristou GI, Muddana V, Yadav D, et al. Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol 2010 ; 105 : 435-41.
[30]Sharma V., Rana S.S., Sharma R. Naso-jejunal fluid resuscitation in predicted severe acute pancreatitis : Randomized comparative study with intravenous Ringer's lactate. J Gastroenterol Hepatol. 2016;31:265-269.
[31]Perner A., Haase N., Guttormsen A.B. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124-134.
[32]Wu B.U., Hwang J.Q., Gardner T.H. Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;8:710-717.
[33]Aggarwal A., Manrai M., Kochhar R. Fluid resuscitation in acute pancreatitis. World J Gastroenterol. 2014;20:18092-18103.
[34]Meng W., Yuan J., Zhang C. Parenteral analgesics for pain relief in acute pancreatitis: A systematic review. Pancreatology. 2013;13:201-206.
[35]Basurto Ona X., Rigau Comas D., Urrútia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev. 2013;7:CD009179.
[36]Wittau M, Mayer B, Scheele J, et al. Systematic review and meta-analysis of antibiotic prophylaxis in severe acute pancreatitis. Scand J Gastroenterol 2011 ; 46 : 261-70.
[37]Villatoro E., Mulla M., Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2010;5:CD002941.
[38]Luiten E.J., Hop W.C., Lange J.F., Bruining H.A. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57 e65.
[39]Besselink M.G., Van Santvoort H.C., Buskens E. Probiotic prophylaxis in predicted severe acute pancreatitis : a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651-659.
[40]Asrani V., Chang W.K., Dong Z. Glutamine supplementation in acute pancreatitis: A meta-analysis of randomized controlled trials. Pancreatology. 2013;13:468-474.
[41]Siriwardena A.K., Mason J.M., Balachandra S. Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut. 2007;56:1439-1444.
[42]Rebours V., Boudaoud L., Vullierme M.P. Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophilia. Am J Gastroenterol. 2012;107:1579-1585.
[43]Xu W., Qi X., Chen J. Prevalence of splanchnic vein thrombosis in pancreatitis: A systematic review and meta-analysis of observational studies. Gastroenterol Res Pract. 2015;2015:245460.
[44]Zhou J., Ke L., Tong Z. Risk factors and outcome of splanchnic venous thrombosis in patients with necrotizing acute pancreatitis. Thromb Res. 2015;135:68-72.
[45]Zhou J., Ke L., Yang D. Predicting the clinical manifestations in necrotizing acute pancreatitis patients with splanchnic vein thrombosis. Pancreatology. 2016;16:973-978.
[46]Plessier A., Darwish-Murad S., Hernandez-Guerra M. Acute portal vein thrombosis unrelated to cirrhosis : a prospective multicenter follow-up study. Hepatology. 2010;51:210-218.
[47]Garcia-Pagán J.C., Barrufet M., Cardenas A., Escorsell A. Management of gastric varices. Clin Gastroenterol Hepatol. 2014;12:919-928.
[48]Eckerwall G.E., Tingstedt B.B., Bergenzaun P.E. Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery--a randomized clinical study. Clin Nutr. 2007;26:758-763.
[49]Li J., Xue G.J., Liu Y.L. Early oral refeeding wisdom in patients with mild acute pancreatitis. Pancreas. 2013;42:88-91.
[50]van Baal MC, Besselink MG, Bakker OJ, et al. Timing of cholecystectomy after mild biliary pancreatitis : a systematic review. Ann Surg 2012 ; 255 : 860-6.
[51]da Costa DW, Bouwense SA, Schepers NJ, et al. Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): A multicentre randomised controlled trial. Lancet 2015 ; 386 : 1261-8.
[52]Wu L.M., Sankaran S.J., Plank L.D. Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis. Br J Surg. 2014;101:1644-1656.
[53]Al-Omran M., Albalawi Z.H., Tashkandi M.F. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev. 2010;1:CD002837.
[54]Eatock FC, Chong P, Menezes N, et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol 2005 ; 100 : 432-9.
[55]Kumar A., Singh N., Prakash S. Early enteral nutrition in severe acute pancreatitis: A prospective randomized controlled trial comparing nasojejunal and nasogastric routes. J Clin Gastroenterol. 2006;40:431-434.
[56]Bakker OJ, van Brunschot S, van Santvoort HC, et al. Early versus on-demand nasoenteric tube feeding in acute pancreatitis. N Engl J Med 2014 ; 371 : 1983-93.
[57]Bakker O.J., van Santvoort H., Besselink M.G. Extrapancreatic necrosis without pancreatic parenchymal necrosis : a separate entity in necrotising pancreatitis? Gut. 2013;62:1475-1480.
[58]Sanjay P., Yeeting S., Whigham C. Endoscopic sphincterotomy and interval cholecystectomy are reasonable alternatives to index cholecystectomy in severe acute gallstone pancreatitis. Surg Endosc. 2008;22:1832-1837.
[59]Kochar B., Akshintala V., Afghani E. Incidence, severity, and mortality of post-ERCP pancreatitis: A systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015;81:143-149.
[60]Dumonceau JM, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis : European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2014 ; 46 : 799-815.
[62]Freeman M.L., DiSario J., Nelson D.B. Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc. 2001;54:425-434.
[63]Elmunzer BJ, Scheiman JM, Lehman GA, et al. A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis. N Engl J Med 2012 ; 366 : 1414-22.
[64]Sethi S., Sethi N., Wadhwa V. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2014;43:190-197.
[65]Luo H., Zhao L., Leung J. Routine pre-procedural rectal indometacin versus selective post procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: A multicentre, single-blinded, randomised controlled trial. Lancet. 2016;387:2293-2301.
[66]Otsuka T., Kawazoe S., Nakashita S. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A randomized controlled trial. J Gastroenterol. 2012;47:912-917.
[67]Buxbaum J., Yan A., Yeh K. Aggressive hydration with lactated ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2014;12:303-307.
[68]Wu D., Wan J., Xia L. The efficiency of aggressive hydration with lactated ringer solution for the prevention of post-ERCP pancreatitis: A systematic review and meta analysis. J Clin Gastroenterol. 2017;51:68-76.
[69]Mok S.R.S., Ho H.C., Shah P. Lactated Ringer's solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission : a prospective randomized, double-blinded, placebo-controlled trial. Gastrointest Endosc. 2017;85:1005-1013.
[70]Mazaki T., Mado K., Masuda H. Prophylactic pancreatic stent placement and post ERCP pancreatitis: An updated meta-analysis. J Gastroenterol. 2014;49:343-355.
[71]Das A., Singh V.P., Sivak M. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: A cost-effectiveness analysis. Gastrointest Endosc. 2007;65:960-968.
[72]Afghani E., Akshintala V.S., Khashab M.A. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: A systematic review and network meta-analysis. Endoscopy. 2014;46:173-180.
[73]Akbar A., Abu Dayyeh B.K., Baron T.H. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography : A network meta-analysis. Clin Gastroenterol Hepatol. 2013;11:778-783.
[74]Elmunzer B.J., Serrano J., Chak A. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: Study protocol for a randomized controlled trial. Trials. 2016;17:1-6.
[75]Ducarme G, Maire F, Chatel P, et al. Acute pancreatitis during pregnancy: A review. J Perinatol 2014 ; 34 : 87-94.
[76]Ko C.W., Beresford S.A., Schulte S.J. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology. 2005;41:359-365.
[77]Robertson K.W., Stewart I.S., Imrie C.W. Severe acute pancreatitis and pregnancy. Pancreatology. 2006;6:309-315.
[78]Crisan L.S., Steidl E.T., Rivera-Alsina M.E. Acute hyperlipidemic pancreatitis in pregnancy. Am J Obstet Gynecol. 2008;198:57-59.
[79]Birchard K.R., Brown M.A., Hyslop W.B. MRI of acute abdominal and pelvic pain in pregnant patients. AJR. 2005;184:452-458.
[80]Date RS, Kaushal M, Ramesh A. A review of the management of gallstone disease and its complications in pregnancy. Am J Surg 2008 ; 196 : 599-608.
[81]Othman MO1, Stone E., Hashimi M., Parasher G. Conservative management of cholelithiasis and its complications in pregnancy is associated with recurrent symptoms and more emergency department visits. Gastrointest Endosc. 2012;76:564-569.
[82]Yumi H. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. Surg Endosc. 2008;22:849-861.
[83]Tang S.J., Mayo M.J., Rodriguez-Frias E. Safety and utility of ERCP during pregnancy. Gastrointest Endosc. 2009;69:453-461.
[84]Nikkola J1, Laukkarinen J, Lahtela J, et al. The long-term prospective follow-up of pancreatic function after the first episode of acute alcoholic pancreatitis: Recurrence predisposes one to pancreatic dysfunction and pancreatogenic diabetes. J Clin Gastroenterol 2017 ; 51 : 183-90.
[85]Umapathy C., Raina A., Saligram S. Natural history after acute necrotizing pancreatitis: A large US tertiary care experience. J Gastrointest Surg. 2016;20:1844-1853.
[86]Chandrasekaran P., Gupta R., Shenvi S. Prospective comparison of long term outcomes in patients with severe acute pancreatitis managed by operative and non operative measures. Pancreatology. 2015;15:478-484.
[87]Machicado J.D., Gougol A., Stello K. Acute pancreatitis has a long-term deleterious effect on physical health related quality of life. Clin Gastroenterol Hepatol. 2017;15:1435-1443.
[88]Lin S.Y., Hsu W.H., Lin C.C. Effect of acute pancreatitis on the risk of developing osteoporosis: A nationwide cohort study. PLoS One. 2017;12:e0179358.